Supernus (SUPN) Return on Sales [ROS] (2022 - 2026)
Supernus Pharmaceuticals' Return on Sales [ROS] was 9.34% in Q3 2026, up 40.69 percentage points from -31.35% a year earlier and up 35.80 percentage points from the prior quarter.
Supernus (SUPN) Return on Sales [ROS] (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Supernus Pharmaceuticals' Return on Sales [ROS] was -11.88% through Sep 30, 2026, down 6.46 percentage points year-over-year; for FY2025, it came in at -8.66%, down 21.00 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of -42.04 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was 12.34% in FY2024 (+13.21 pp), -0.87% in FY2023 (-7.78 pp), 6.91% in FY2022 (-7.93 pp) and 14.84% in FY2021 (-18.54 pp).
- The Q3 2026 figure marks the highest quarterly Return on Sales [ROS] since Q4 2024.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last seven quarters, with an average year-over-year change of -8.53 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2026 (a gain of 40.69 percentage points); the worst was Q3 2025 (a drop of 54.60 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Supernus | 3.39 Bn | 2.50 Bn | 305.00 Mn | 50.56% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 50.56% |
| Jun 30, 2026 | 46.65% |
| Mar 31, 2026 | 43.22% |
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 13.69% |
| Jun 30, 2025 | 23.84% |
| Mar 31, 2025 | 24.81% |
| Dec 31, 2024 | 15.38% |
| Sep 30, 2024 | 11.40% |
| Jun 30, 2024 | -39.46% |
| Mar 31, 2024 | 26.41% |
| Dec 31, 2023 | 20.48% |
| Sep 30, 2023 | -67.53% |
| Jun 30, 2023 | 22.10% |
| Mar 31, 2023 | 22.53% |
| Dec 31, 2022 | -107.05% |
| Sep 30, 2022 | 24.14% |
| Jun 30, 2022 | 28.51% |
Supernus Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();